Literature DB >> 1939011

Characterization and changes of glycosphingolipids in the aorta of the Watanabe hereditable hyperlipidemic rabbit.

A Hara1, T Taketomi.   

Abstract

Characterization and elucidation of the changes of glycosphingolipids in the aorta along with the progression of atherosclerosis were performed in the Watanabe hereditable hyperlipidemic (WHHL) rabbit, an animal model for human familial hypercholesterolemia, as compared with in the normal rabbit. Neutral glycosphingolipids in aortae of both normal and WHHL rabbits were composed of glucosylceramide, galactosylceramide, lactosylceramide, globotriaosylceramide, globotetraosylceramide, and galactosylneolactotetraosylceramide. The total amount of neutral glycosphingolipids in the aorta of the WHHL rabbit (557 nmol/g tissue) was increased about 5-fold compared to the normal level (107 nmol/g tissue). Prominent increases were observed in glucosylceramide (13-fold the normal level) and lactosylceramide (12-fold the normal level). The amount of total gangliosides in the aorta of the WHHL rabbit (207 micrograms NeuAc/g tissue) was markedly increased, being about 12-fold the normal level (17 micrograms NeuAc/g tissue). GM3 ganglioside was increased about 11-fold compared to normal. GD3 ganglioside, which was almost undetectable in normal aorta, also showed a marked increase in that of the WHHL rabbit (51.7 micrograms NeuAc/g tissue). Sulfatide, which was absent in the aorta of the normal rabbit, was markedly accumulated in that of the WHHL rabbit (280 nmol/g tissue). The fatty acid composition of neutral glycosphingolipids of WHHL rabbit was found to include a higher amount of C23:0, which is the major fatty acid of glycolipids in serum lipoproteins. Gangliosides in the aorta of the WHHL rabbit contained more C16:0 than in the normal rabbit. Sphingosine of sulfatide in the aorta of the WHHL rabbit was composed of sphingenine (86%), sphinganine (9%), 4-D-hydroxysphinganine (4%), and 4-D-hydroxyeicosasphinganine (less than 1%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939011     DOI: 10.1093/oxfordjournals.jbchem.a123478

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  11 in total

Review 1.  Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor.

Authors:  N Taniguchi; S Ihara; T Saito; E Miyoshi; Y Ikeda; K Honke
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice.

Authors:  Yosuke Yamada; Makoto Harada; Koji Hashimoto; Ran Guo; Takero Nakajima; Toshihide Kashihara; Mitsuhiko Yamada; Toshifumi Aoyama; Yuji Kamijo
Journal:  Glycoconj J       Date:  2018-12-10       Impact factor: 2.916

3.  Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model.

Authors:  M Kyogashima; J Onaya; A Hara; T Taketomi
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

4.  Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count.

Authors:  Lixuan Wang; Yuji Kamijo; Akihiro Matsumoto; Takero Nakajima; Makoto Higuchi; Reiji Kannagi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Glycoconj J       Date:  2011-04-19       Impact factor: 2.916

5.  Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system.

Authors:  M Kyogashima; T Sakai; J Onaya; A Hara
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

6.  Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.

Authors:  Rui Hu; Gang Li; Yuji Kamijo; Toshifumi Aoyama; Takero Nakajima; Teruo Inoue; Koichi Node; Reiji Kannagi; Mamoru Kyogashima; Atsushi Hara
Journal:  Glycoconj J       Date:  2007-07-27       Impact factor: 2.916

7.  Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice.

Authors:  Hiroki Kanbe; Yuji Kamijo; Takero Nakajima; Naoki Tanaka; Eiko Sugiyama; Lixuan Wang; Zhong-Ze Fang; Atsushi Hara; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Arch Toxicol       Date:  2013-09-25       Impact factor: 5.153

Review 8.  Gangliosides and atherosclerosis.

Authors:  N V Prokazova; L D Bergelson
Journal:  Lipids       Date:  1994-01       Impact factor: 1.880

9.  Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen.

Authors:  A Hara; K Uemura; T Taketomi
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

10.  Identification of the differentially expressed genes associated with familial combined hyperlipidemia using bioinformatics analysis.

Authors:  Xiaoli Luo; Changqing Yu; Chunjiang Fu; Weibin Shi; Xukai Wang; Chunyu Zeng; Hongyong Wang
Journal:  Mol Med Rep       Date:  2015-01-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.